Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announced today the determination of the stock dividend ratio related to the dividend for the year ended 31 December 2011 as approved by the Annual General Meeting of Shareholders on 16 May 2012.
The average price during the period 18 May 2012 up to and including 1 June 2012 was 3.47. The number of dividend rights giving entitlement to one Cryo-Save Group N.V. share has on 1 June 2012 (after market) been set at 43 (or at the choice of the banks or stockbroker where a shareholder holds its shares 4,300 dividend rights gives entitlement to 100 shares). Payment of stock dividend is only made in whole shares; fractions of shares are settled in cash.
The Group announces that shareholders wish to receive a distribution in shares for 29% of the total dividend.
The cash distribution will be payable and the shares will be delivered as per 14 June 2012.
In this context a total of approximately 63,000 new shares will be issued, charged to the share premium reserve, representing a Euro equivalent of approximately 216,000. The cash dividend will amount to 526,000 before withholding 15% dividend withholding tax.
Paying Agent: Kempen & Co N.V.
| Cryo-Save Group || + 31 (0) 575 548 998 |
| Arnoud van Tulder, Chief Executive Officer || |
| || |
| SPJ Financiële Communicatie (The Netherlands) || +31 (0)20 647 8181 |
| Kees Jongsma/Leon Melens || |
| Daniel Stewart & Company plc (UK) || + 44 (0) 20 7776 6550 |
| Martin Lampshire || |
| || |
| College Hill (UK) || + 44 (0) 20 7457 2020 |
| Rozi Morris/ Adrian Duffield || |
Free footage is available on www.videobankonline.com:
About Cryo-Save (www.cryo-save.com/group:
Cryo-Save, the leading international family stem cell bank, stores more than 200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on 3 continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE